5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Evaluation of Vitamin D, Vitamin D Binding Protein Gene Polymorphism with Oxidant – Antioxidant Profiles in Chronic Obstructive Pulmonary Disease Translated title: PROCENA POVEZANOSTI VITAMINA D I POLIMORFIZMA GENA ZA VITAMIN D-VEZUJUĆI PROTEIN SA OKSIDANTNIM–ANTIOKSIDANTNIM PROFILIMA U HRONIČNOJ OPSTRUKTIVNOJ BOLESTI PLUĆA

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Background

          The aim was to evaluate the association of plasma 25-hydroxyvitamin D (25-OHD) and vitamin D binding protein (VDBP or Gc-globin) gene polymorphism with oxidant-antioxidant profiles in patients with chronic obstructive pulmonary disease (COPD), and their role as biomarker risk factors in susceptibility and severity of COPD.

          Methods

          Eighty patients diagnosed with COPD (mild, moderate and severe according to lung function tests; FEV 1%) and 80 healthy controls were included in the study. Serum nitric oxide (NO) and lipid peroxide (LP), plasma reduced glutathione (RGSH), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) activity, 25-OHD and VDBP polymorphism were analyzed in all subjects.

          Results

          COPD patients had significantly decreased serum NO, plasma SOD, RGSH, GSH-Px, CAT and 25-OHD versus controls, but had significantly increased serum LP. In COPD patients, 25-OHD levels were significantly lower (41.49± 13.65 ng/mL) versus controls, but more lower in severe COPD patients (30.54±9.09 ng/mL; sensitivity 79.2%; spe - cificity 73.2%, p<0.001) versus mild and moderate COPD. VDBP genotypes frequencies were Gc1S-1S=23.8%, Gc1F-1S=28.8%, Gc1F-1F=15%, Gc1S-2=20%, Gc1F-2=11.3% and Gc2-2=1.3%. Also, VDBP variants frequencies were Gc1S=48.1%, Gc1F=35% and Gc2=16.6%. How ever, Gc1F-1S genotypes and Gc1F variants were significantly higher than in controls (10%, 12.5%; p=0.009, p=0.001, respectively). Moreover, in severe COPD patients, Gc1F-1S genotype was significantly higher than in mild COPD (41.7% vs 31.3%, p=0.04).

          Conclusion

          COPD patients had significantly lower plasma 25-OHD and were associated with significantly higher VDBP Gc1F-1S genotypes and Gc1F variants frequencies than controls. Low vitamin D levels and VDBP polymorphism may be important as diagnostic risk factors in the susceptibility to and severity of COPD.

          Kratak sadržaj

          Uvod

          Cilj je bio da se utvrdi povezanost između 25-hidroksivitamina D (25-OHD) u plazmi i polimorfizma gena za vitamin D-vezujući protein ( vitamin D-binding protein, VDBP ili Gc-globin) i oksidantnih–antioksidantnih profila kod pacijenata sa hroničnom opstruktivnom bolešću pluća (HOBP), kao i njihova uloga kao faktora rizika biomarkera za podložnost i ozbiljnost HOBP.

          Metode

          U ovu studiju je uključeno 80 pacijenata sa dijagnozom HOBP (blag, umeren i težak oblik na osnovu testova plućne funkcije; FEV 1%) i 80 zdravih kontrolnih ispitanika. Kod svih ispitanika analizirani su nivoi azot-oksida (NO) i lipidperoksida (LP) u serumu, redukovani glutation (RGSH), superoksid-dismutaza (SOD), glutation peroksidaza (GSH/Px) u plazmi, aktivnosti katalaze (CAT), 25-OHD i polimorfizam VDBP.

          Rezultati

          Oboleli od HOBP imali su značajno snižene nivoe NO u serumu, SOD, RGSH, GSH-Px, CAT i 25-OHD u plazmi u poređenju s kontrolom, ali značajno povišen serumski LP. Kod obolelih od HOBP, nivoi 25-OHD bili su značajno niži (41,49±13,65 ng/mL) u odnosu na kontrolu, ali jo{ niži kod pacijenata sa teškim oblikom HOBP (30,54±9,09 ng/mL; osetljivost 79,2%; specifičnost 73,2%, p<0,001) u poređenju s blagim ili umerenim oblicima HOBP. Učestalost genotipova VDBP bila je Gc1S-1S=23,8%, Gc1F-1S=28,8%, Gc1F-1F=15%, Gc1S-2=20%, Gc1F-2=11,3% i Gc2-2=1,3%. Takođe, učestalost varijanti VDBP bila je Gc1s=48,1%, Gc1F=35% i Gc2=16,6%. Međutim, genotipovi Gc1F-1S i varijante Gc1F bili su značajno viši nego kod kontrolne grupe (10%, odnosno 12,5%; p=0,009, odnosno p=0,001). Štaviše, kod pacijenata sa teškim oblikom HOBP, genotip Gc1F-1S bio je značajno češči nego u blagoj HOBP (41,7% prema 31,3%, p=0,04).

          Zaključak

          Oboleli od HOBP imali su značajno niže nivoe 25-OHD u plazmi i utvr|ena je povezanost sa značajno većom učestalošću VDBP genotipova Gc1F-1S i varijanti Gc1F nego kod kontrolnih subjekata. Niski nivoi vitamina D i polimorfizam VDBP mogu biti važni kao dijagnostički faktori rizika u podložnosti i stepenu ozbiljnosti HOBP.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood.

          Concentrations of a peroxidation product (malondialdehyde), fluorescent chromophores, lipofuscin-like fluorescent products, superoxide dismutase, catalase, glutathione peroxidase, and vitamin E in the maternal blood and the cord blood were determined and the results obtained were related to the estimation of lipid peroxidation and protective mechanism against uncontrolled oxidative processes in late pregnancy. Serum levels of fluorescent products were higher in the maternal blood than in the cord blood, indicating less frequent lipid peroxidation in the fetus than in the mother. In support of this assumption, the three protective enzymes and vitamin E were present in relatively lower concentrations in the cord blood. Sudden exposure of the newborn infant to a normobaric atmosphere after beginning breathing seems, therefore, to cause oxidation of red blood cell membrane, denaturation of the membrane, inducing hemoglobin breakdown, and consequently hemolysis.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            COPD: balancing oxidants and antioxidants

            Chronic obstructive pulmonary disease (COPD) is one of the most common chronic illnesses in the world. The disease encompasses emphysema, chronic bronchitis, and small airway obstruction and can be caused by environmental exposures, primarily cigarette smoking. Since only a small subset of smokers develop COPD, it is believed that host factors interact with the environment to increase the propensity to develop disease. The major pathogenic factors causing disease include infection and inflammation, protease and antiprotease imbalance, and oxidative stress overwhelming antioxidant defenses. In this review, we will discuss the major environmental and host sources for oxidative stress; discuss how oxidative stress regulates chronic bronchitis; review the latest information on genetic predisposition to COPD, specifically focusing on oxidant/antioxidant imbalance; and review future antioxidant therapeutic options for COPD. The complexity of COPD will necessitate a multi-target therapeutic approach. It is likely that antioxidant supplementation and dietary antioxidants will have a place in these future combination therapies.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The role of the vitamin D endocrine system in health and disease.

                Bookmark

                Author and article information

                Journal
                J Med Biochem
                J Med Biochem
                jomb
                jomb
                Journal of Medical Biochemistry
                Sciendo
                1452-8258
                1452-8266
                October 2017
                28 October 2017
                : 36
                : 4
                : 331-340
                Affiliations
                [1 ]Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, Sadat City University , Sadat, Egypt
                [2 ]Department of Chest Diseases, Zagazig Faculty of Medicine, Zagazig University , Zagazig, Egypt
                [3 ]Departments of Medical Biochemistry, Faculty of Medicine, Menoufiya University , Menoufiya, Egypt
                [4 ]Departments of Medical Biochemistry, College of Medicine, Al-Mustansiriyah University , Baghdad, Iraq
                Author notes
                [* ] Dr. Mahmood A. Al-Azzawi, PhD. Departments of Medical Biochemistry, College of Medicine, Al-Mustansiriyah University, Baghdad, Iraq Mobile: 002-01066154122 mmahmood41@ 123456yahoo.com
                Article
                jomb-2017-0012
                10.1515/jomb-2017-0012
                6294086
                6f69b190-5a15-4b4a-b35e-d1ec8ff230fc
                © 2017 Mahmood A. Al-Azzawi, Adel H. Ghoneim, Ibrahim Elmadbouh, published by Sciendo

                This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

                History
                : 14 December 2016
                : 02 March 2017
                Page count
                Pages: 10
                Categories
                Original Paper

                vitamin d,copd,vdbp polymorphism,lung function,smoking,oxidants-antioxidants,hobp,polimorfizam vdbp,plućna funkcija,pušenje,oksidanti–antioksidanti

                Comments

                Comment on this article